Biomea Fusion, Inc. 8-K

What Happened

• Biomea Fusion, Inc. (BMEA) filed a Current Report on Form 8‑K on January 14, 2026 disclosing that the company presented at the 44th Annual J.P. Morgan Healthcare Conference (held Jan 12–15, 2026) in San Francisco.
• The company posted the conference presentation to its Investors & Media website and furnished that presentation as Exhibit 99.1 to the 8‑K.
• On the same date, Biomea updated its corporate presentation used with investors and analysts and furnished it as Exhibit 99.2.

Key Details

• Date of filing/presentations: January 14, 2026 (conference ran Jan 12–15, 2026).
• Materials posted and furnished: Conference Presentation (Exhibit 99.1) and Corporate Presentation (Exhibit 99.2).
• Presentations available on the company’s investor website: www.biomeafusion.com.
• The filings include the company’s usual forward‑looking statements caution regarding development plans and clinical expectations.

Why It Matters

• For investors, the posted slide decks are the primary source for any updates Biomea provided at the conference—such as program status, timelines, or strategy—so reviewing those exhibits can clarify near‑term development plans.
• This 8‑K does not report financial results or management changes; it simply makes the company’s investor materials publicly available and documents the presentation for regulatory purposes.